Ampio Pharmaceuticals Inc

ASE:AMPE  
1.85
+0.13 (+7.56%)
Products

FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients

Published: 09/21/2020 13:30 GMT
Ampio Pharmaceuticals Inc (AMPE) - FDA Grants Ind and Approves Clinical Trial Protocol of Inhaled Ampion for Covid-19 Patients With Respiratory Distress.